Bioworld by clarivate releases comprehensive 2024 year in review

Series recaps biopharma, medtech, and science trends and breakthroughs that shaped the year london , jan. 16, 2025 /prnewswire/ -- bioworld™ published by clarivate plc (nyse:clvt), a leading global provider of transformative intelligence, has released its highly anticipated 2024 year in review series. this multipart special report offers an in-depth analysis of the therapeutic trends, regulatory actions and economic shifts that defined biopharma, med tech and scientific innovation over the past year while forecasting key developments for 2025.
CLVT Ratings Summary
CLVT Quant Ranking